Gazyva (obinutuzumab)

pCPA File Number: 21015

Negotiation Status:

Concluded with an LOI

Indication(s):

Follicular Lymphoma

Sponsor/Manufacturer:

Hoffmann-La Roche

CADTH Project Number:

pCODR 10091

pCPA Engagement Letter Issued:

2017-10-10

Negotiation Process Concluded:

2018-01-16